Search

everythinglearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Effective treatments for severe alopecia areata are still lacking.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Leflunomide is more likely to help treat alopecia areata than cause it.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Edar signaling is crucial for controlling hair growth and regression.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.